Next Article in Journal
Genetic Effects Analysis of QTLs for Rice Grain Size Based on CSSL-Z403 and Its Dissected Single and Dual-Segment Substitution Lines
Next Article in Special Issue
Carnation Italian Ringspot Virus p36 Expression Induces Mitochondrial Fission and Respiratory Chain Complex Impairment in Yeast
Previous Article in Journal
Inhibition of Topoisomerases by Metal Thiosemicarbazone Complexes
Previous Article in Special Issue
Cell-Based Measurement of Mitochondrial Function in Human Airway Smooth Muscle Cells
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 24
Issue 15
10.3390/ijms241512011
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Yeast Bax Inhibitor (Bxi1p/Ybh3p) Is Not Required for the Action of Bcl-2 Family Proteins on Cell Viability

by
Marek Mentel
,
Miroslava Illová
,
Veronika Krajčovičová
,
Gabriela Kroupová
,
Zuzana Mannová
,
Petra Chovančíková
and
Peter Polčic
*
Department of Biochemistry, Faculty of Natural Sciences, Comenius University in Bratislava, Mlynská Dolina CH1, Ilkovičova 6, 84215 Bratislava, Slovakia
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2023, 24(15), 12011; https://doi.org/10.3390/ijms241512011
Submission received: 30 June 2023 / Revised: 20 July 2023 / Accepted: 25 July 2023 / Published: 27 July 2023
(This article belongs to the Special Issue Mitochondrial Research: Yeast and Human Cells as Models 2.0)
Browse Figures
Review Reports Versions Notes

Abstract

:
Permeabilization of mitochondrial membrane by proteins of the BCL-2 family is a key decisive event in the induction of apoptosis in mammalian cells. Although yeast does not have homologs of the BCL-2 family, when these are expressed in yeast, they modulate the survival of cells in a way that corresponds to their activity in mammalian cells. The yeast gene, alternatively referred to as BXI1 or YBH3, encodes for membrane protein in the endoplasmic reticulum that was, contradictorily, shown to either inhibit Bax or to be required for Bax activity. We have tested the effect of the deletion of this gene on the pro-apoptotic activity of Bax and Bak and the anti-apoptotic activity of Bcl-XL and Bcl-2, as well on survival after treatment with inducers of regulated cell death in yeast, hydrogen peroxide and acetic acid. While deletion resulted in increased sensitivity to acetic acid, it did not affect the sensitivity to hydrogen peroxide nor to BCL-2 family members. Thus, our results do not support any model in which the activity of BCL-2 family members is directly affected by BXI1 but rather indicate that it may participate in modulating survival in response to some specific forms of stress.

1. Introduction

In the course of evolution, living organisms developed multiple mechanisms to increase survival under various adverse conditions. These involve several forms of programmed cell death, including apoptosis in animals, to maintain tissues or populations of cells, as well as processes such as autophagy, unfolded protein response, or oxidative stress response to maintain the functionality of individual cells.
Proteins of the BCL-2 protein family are involved in the regulation of apoptosis. They integrate multiple upstream death- or survival-promoting signals, to which they respond by permeabilization of the outer mitochondrial membrane, leading to the release of the cytochrome c from mitochondria into the cytosol and activation of caspases [1]. The BCL-2 family comprises proteins that are characterized by the presence of at least one of four sequence motifs (BH1-BH4, Bcl-2 homology) homologous to the founding member of the family: Bcl-2. The family consists of both pro-apoptotic proteins, which promote membrane permeabilization, and anti-apoptotic proteins, such as Bcl-2 and Bcl-XL, that support cell survival by preventing it. The function of individual members of the family correlates with the presence of BH motifs. While anti-apoptotic proteins contain all four BH motifs, all pro-apoptotic members lack BH4. They are further divided into two subclasses, multidomain pro-apoptotic proteins, e.g., Bax and Bak, which contain BH1–BH3 and are required to directly permeabilize the membrane and BH3-only proteins, which only contain BH3 and act as sensors that activate Bax and Bak [2,3,4].
Although regulated cell death in yeast does rely on different pathways than in mammalian cells [5,6] and the yeast genome does not contain homologs of BCL-2 family genes, when mammalian pro-apoptotic members of the family Bax and Bak are expressed in yeast, they induce cell killing [7]. Furthermore, the killing of yeast cells by Bax or Bak can be modulated by both anti-apoptotic BCL-2 family members and BH3-only proteins [8,9,10,11]. This, indeed, makes yeast an attractive model for the investigation of the regulation of mammalian apoptosis [12,13]. In one of the early yeast-based screenings of mammalian genes that suppress the ability of Bax to kill yeast cells, a membrane protein localized in endoplasmic reticulum, BI-1 (Bax inhibitor-1), was identified [14]. Unlike anti-apoptotic members of the Bcl-2 family, BI-1 does not inhibit Bax by direct interaction. Rather it was shown to be a Ca2+ channel that participates in the regulation of unfolded protein response by IRE1 [15] but also in response to calcium imbalance, reactive oxygen species accumulation, and metabolic dysregulation [16].
BI-1 became a founding member of the protein superfamily TMBIM (Transmembrane Bax inhibitor containing motif) that comprises homologous proteins, which share the common membrane topology [17] but differ in their subcellular localization (e.g., Golgi apparatus, endoplasmic reticulum, and mitochondria) and most of which have anti-apoptotic activity [18,19].
In yeast Saccharomyces cerevisiae, a homolog of mammalian BI-1 was identified [20] and named BXI1 (Bax-inhibitor 1) [21]. It was shown to enhance yeast survival under conditions that induce increased levels of unfolded proteins in the endoplasmic reticulum, such as high temperature, β-mercaptoethanol or tunicamycin treatment, suggesting that it may play a role in unfolded protein response [21].
Interestingly, the same protein was in an independent study identified by in silico screening as a protein containing a motif similar to the BH3 domain of the mammalian BCL-2 family proteins. Named YBH3 (Yeast BH3-only), it was shown to potentiate the killing of cells by Bax, as mutant cells lacking a functional copy of the gene survived better under conditions of Bax expression [22]. The effect of Ybh3 on Bax-mediated killing was shown to be dependent on the presence of mitochondrial phosphate carrier Mir1. Furthermore, Ybh3 was shown to participate in regulated cell death induced by acetic acid and hydrogen peroxide [22].
In this study, we tested the effect of the deletion of BXI1 and MIR1 on the pro-apoptotic activity of Bax and Bak and the anti-apoptotic activity of Bcl-XL and Bcl-2, as well on survival after treatment with inducers of regulated cell death in yeast, hydrogen peroxide and acetic acid. Our results do not support any model in which the activity of BCL-2 family members is directly affected by BXI1.

2. Results

To evaluate the effect of Bxi1p on cell death in yeast induced by ectopic expression of Bax and Bak, the recombinant genes enabling the galactose-inducible expression of HA-tagged version of murine Bax and Bak were integrated into the genome of wild type (CML282) and ∆bxi1 (CML282∆bxi1) strains. As expected, the growth of the CML282-GHBax strain on media containing 0.1% or more galactose is seriously compromised (Figure 1) as compared to the growth of the control strain (CML282) due to the expression of Bax. The same growth defect on galactose-containing plates was also observed in the growth of CML∆bxi1-GHBax. The sensitivity of both strains to the galactose-induced effects of Bax was identical regardless of the presence of the wild-type BXI1 allele (Figure 1). The same results were also observed with the strains expressing Bak.
The effect of the expression of Bax and Bak on yeast cell growth can be suppressed by simultaneous expression of anti-apoptotic proteins Bcl-XL or Bcl-2 [7,23,24]. To see whether or not the function of these anti-apoptotic proteins can be affected by the absence of Bxi1p, we further transformed the wild type and ∆bxi1 strains containing integrated Bax or Bak genes with plasmids, enabling the tetracycline-inducible expression of HA-tagged murine Bcl-XL or Bcl-2. While all the strains containing Bax and Bak genes failed to grow on galactose-containing plates without tetracycline analog, doxycycline, strains containing plasmids with Bcl-XL restored growth when at least 0.1 mg/L doxycycline was present in cultivation media (Figure 2). Absence (∆bxi1) or presence of functional BXI1 allele did not affect the growth of these strains.
To test the role of mitochondrial phosphate carrier isoform Mir1 in the cell death modulating activity of Bxi1 and BCL-2 family proteins, the strains with additional deletion of the MIR1 gene were prepared (CML∆mir1, CML∆bxi1∆mir1). As in the experiment described above, the genes enabling the expression of Bax or Bak were integrated into their genomes (CML∆mir1-GHBax, CML∆bxi1∆mir1-GHBax and CML∆mir1-GHBak, CML∆bxi1∆mir1-GHBak, respectively) and resulting strains were transformed with plasmids, enabling the expression of Bcl-XL (pCM252-HABcl-XL) or with control plasmids (pCM252).
The deletion of MIR1 alone did not affect either the growth of strains expressing pro-apoptotic Bax (Figure 3a) nor did it affect the growth of strain co-expressing Bax and anti-apoptotic protein Bcl-XL (Figure 3b). The same results were obtained with Bak and Bcl-2.
As it is shown on Figure 4, the deletion of MIR1 gene also did not affect neither the growth inhibition by Bax, nor the growth restoration by Bcl-XL in ∆bxi1 strains. These data together indicate that the absence of BXI1, MIR1 or the combined absence of both does not affect the activity of BCL-2 family proteins in yeast.
As it was suggested that the BXI1 may play a role in regulated cell death in yeast induced by acetic acid or hydrogen peroxide [22], we have also tested the sensitivity of CML∆bxi1 to the treatment with these two compounds. While the sensitivity of the deletion strain to hydrogen peroxide was essentially the same as the sensitivity of the wild type (Figure 5a), the deletion strain showed increased sensitivity to acetic acid (Figure 5b).

3. Discussion

Budding yeast is a unicellular eukaryotic organism that has been traditionally used as a model to study processes typical for eukaryotic cells, including mammalian cells. While many pathways present in mammalian cells are well conserved and have obvious homologs in yeast, others may differ. A typical representative of the latter is programmed cell death. Unlike in mammalian apoptosis, the pathways of regulated cell death in yeast do not rely on the permeabilization of mitochondrial membrane by BCL-2 family, and the yeast genome also does not encode for homologs of BCL-2 family proteins. Surprisingly, the yeast genome, as also genomes of other eukaryotic organisms, including those who do not have apoptotic pathway dependent on the BCL-2 family, does encode for a homolog of mammalian BI-1. Moreover, a yeast homolog contains a sequence motif similar to the BH3 domain of BCL-2 family proteins. The study suggested that, as the only yeast BH3-only protein, it may be required for the pro-apoptotic activity of Bax and Bak when ectopically expressed in yeast cells [22]. As this observation appears to contradict the ability of BI-1 to inhibit Bax, we tested the response of wild-type yeast strain and deletion mutant lacking a functional copy of BXI1 to survive the expression of pro-apoptotic and anti-apoptotic BCL-2 family proteins. The employed expression system enabled us to modulate the expression of these proteins by varying the concentration of inducers (galactose and doxycycline) in cultivation media [9]. In these experiments, the growth of the ∆bxi1 strain did not differ from the growth of the wild-type strain, even in the conditions when the lowest concentration of inducers required for the phenotypic effect was used (e.g., 0.1% galactose or 0.1 μg/mL doxycycline). This indicates that the absence of Bxi1p affects neither the ability of Bax or Bak to kill cells nor the ability of Bcl-XL or Bcl-2 to rescue cell growth. The same system has been previously shown to be suitable to detect the activity of mammalian BH3-only proteins [10,11]. Our data, therefore, strongly indicate that the motif identified in Bxi1p is not a functional BH3 domain.
At the molecular level, the function of the BH3 domain in mammalian BCL-2 family proteins is to facilitate the protein–protein interactions between family members by binding to the hydrophobic pocket in the partner protein [25,26,27]. This hydrophobic pocket is present on multi-domain family members (e.g., Bax, Bak, Bcl-XL, Bcl-2) and is also formed by BH domains [28]. Therefore, the conclusion that Bxi1p is not a yeast BH3-only protein would, indeed, also be consistent with the absence of BCl-2 family proteins in yeast.
The killing of yeast cells by Bax has been shown to depend on the integration of Bax into mitochondrial membranes [9]. This integration then leads to the formation of pores in the membranes, which correspond to pores formed by Bax in mammalian mitochondria [29]. Unlike in mammalian cells, the subsequent release of cytochrome c from mitochondrial intermembrane space into cytosol is not required for cell killing [30,31]. Presence of these pores itself is likely incompatible with yeast cells survival, e.g., due to its interference with mitochondrial biogenesis [32]. The same efficiency of the killing of yeast cells by Bax in the presence and the absence of BXI1, observed in this work, then suggests that the ability of Bax to integrate to mitochondrial membranes and to form pores is not affected by Bxi1p.
As we observed that the sensitivity of all tested deletion strains to the action of BCL-2 family proteins was the same as in the wild-type cells, our data not only indicate that BXI1 is not required for the activity of BCL-2 family proteins in yeast but also imply that the absence Bxi1p or its presence in normal level, i.e., not overexpressed, do not affect the downstream responses of yeast cells that may affect the survival in this situation.
Despite the absence of any observable effect of the deletion of BXI1 on the activity of BCL-2 proteins, we further tested whether their activity could be affected by the deletion of MIR1. This gene encodes for a major mitochondrial phosphate carrier isoform [33] and was suggested to be indispensable for the effect of Bxi1p (Ybh3p) on Bax activity [22]. Besides the minute effect on the growth rate of ∆mir1 cells on galactose-based media, we did not observe any effect of MIR1 deletion on the growth of BCL-2 family proteins expressing cells, neither in the presence nor in the absence of BXI1. Thus, Mir1p appears not to play a role in the permeabilization of membranes by pro-apoptotic BCL-2 proteins, neither in the cell-rescuing activity of anti-apoptotic BCL-2 proteins and by extension also in any downstream pathway that affects the survival upon expression of BCL-2 family proteins.
It has been somehow contradictory suggested that Bxi1p is involved in the response to some forms of stress not related to the action of the BCL-2 family. These include the regulated cell death induced by the treatment of cells with hydrogen peroxide or acetic acid, in which the activity of Bxi1p (Ybh3p) was reported to promote cell death [22]. Similarly, the presence of Bxi1p was shown to be required for the toxicity of ectopically expressed human TDP-43, which is a protein found deposited as inclusions in the brain of patients with amyotrophic lateral sclerosis (ALS) [34]. On the other hand, Bxi1p supports survival under conditions of endoplasmic reticulum stress [21]. No effect of deletion of BXI1 was observed in the case of regulated cell death induced by hexadecenal [35]. Cells with either deleted or overexpressed BXI1 grow slightly worse in the media containing elevated concentrations of copper [36]. Contrary to the former [22], in our experiments, we did not observe the protective effect of deletion of BXI1 against the treatment with hydrogen peroxide and acetic acid. Moreover, we observed the increase in sensitivity of ∆bxi1 strain to treatment by acetic acid. Thus, our results are consistent with the idea that Bxi1p is involved in the pathway that responds to some forms of stress to promote cell survival, most likely by acting as a Ca2+ channel in the membrane of the endoplasmic reticulum [37,38]. Although one has to be careful because the extrapolation from mammalian cells may be dubious, this may be also in agreement with the observation of the effects associated with changes in intracellular Ca2+ in BI-1 knock-out mouse [39]. The fact that Bxi1p may be a part of a complex signaling pathway, rather than act directly in some specific process, is also supported by our preliminary results, showing that the effects of deletion of BXI1 on survival in different stress conditions, including the endoplasmic reticulum stress, is strongly strain specific (Polčic et al. unpublished data) and may therefore depend on the activity of many other proteins.
The inhibition of Bax in yeast by overexpression of BI-1 homologs from many organisms, including BXI1, has been well established [14,20]. The mechanism of this inhibition remains to be uncovered. Our data hardly support the model, in which the inhibition relies on the direct interaction of Bxi1p with Bax or other BCL-2 family proteins. This inhibition could thus result from the overactivation of the stress response pathway, e.g., by increased Ca2+-release from the endoplasmic reticulum, downstream of the permeabilization of membranes by Bax.

4. Materials and Methods

4.1. Strains, Plasmids, and Growth Conditions

The wild-type yeast strain used throughout the study is Saccharomyces cerevisiae CML282 (MATa ura3-1, ade2-1, leu2-3, 112; his3-11, 15, trp1-Δ2, can1-100, CMVp(tetR-SSN6)::LEU2) (kindly provided by Enrique Herrero, Universitat de Lleida) [40]. The strain CML∆bxi1, in which the complete coding sequence of BXI1 is replaced with the KanMX4 marker gene (CML282 bxi1::kanMX4), was kindly provided by Nicanor Austriaco (Providence College). The deletion was verified by PCR.
Cells were grown on synthetic complete (SC) media containing the indicated carbon sources and lacking the appropriate amino acids or nucleobases. Yeast cells were transformed by standard lithium acetate protocols [41].
To delete the complete coding sequence of the MIR1 gene, a linear fragment of DNA (deletion cassette), consisting of the URA3 marker gene flanked by 5′UTR and 3′UTR sequences of MIR1, was prepared by PCR using oligonucleotides 5′-CAAGAAGAAGAACTACAAAGATCAAAAAGTCTCATCTCACCGTACGCTGCAGGTCGAC-3′ and 5′-GAGGAGAGAATATATATGCATGTATCAATCAAGACCATTTATCGATGAATTCGAGCTCG-3′ as primers and plasmid pJET-URA3 as a template. This plasmid was prepared by ligation of 1 kbp fragment of URA3, prepared by PCR using oligonucleotides 5′-CGTACGCTGCAGGTCGACGAAGGAAGAACGAAGGAAGG-3′ and 5′-ATCGATGAATTCGAGCTCGGGTAATAACTGATATAATT-3′ as primers and plasmid p416-MET25 [42] as a template, with pJET1.2/blunt vector (ThermoFisher Scientific, Waltham, MA, USA). After a transformation of yeast cells with a deletion cassette, deletants (CML∆mir1, CML∆bxi1∆mir1) were selected by cultivation on SC plates without uracil and verified by PCR.
To express murine Bax or Bak containing N-terminal HA (haemagglutinin) tag, plasmids containing the gene placed behind galactose inducible Gal1/10 promoter—pRS303-GHBax and pRS303-GHBak—were integrated into the HIS3 locus in the chromosome [9,43]. To modulate the expression of Bcl-XL and Bcl-2, cells were transformed with plasmids pCM252-HA-BCL-XL or pCM252-BCL2 [9,11], grown in glucose-based SC media without tryptophan, washed, and transferred to selective liquid or solid media containing the indicated concentration of doxycycline.

4.2. Viability Tests

To assess the activity of BCL-2 family proteins, the growth potential of individual strains expressing corresponding mammalian genes was followed by a drop test. Cells were grown overnight in media containing 2% glucose, diluted to OD600 = 0.5, and 10 μL aliquots of serial 5-fold dilutions were spotted on to test plates containing the indicated concentration of galactose to induce the expression of Bax/Bak and doxycycline to induce the expression of Bcl-XL/Bcl-2. Growth was assessed following incubation at 28 °C for 2–4 days. Experiments were repeated at least three times, representative results are shown.
To assess the survival of cells after treatment with acetic acid, a protocol of Ludovico et al. [44] was followed. Briefly, cells were grown in complete YPG medium (1% yeast extract, 2% bactopeptone, 3% glycerol) until exponential phase, harvested by centrifugation, diluted to cell density corresponding to OD600 = 1 in a same medium supplemented with 80 mM acetic acid and pH adjusted to 3 (and to control medium with the same pH but without acetic acid), and incubated at 28 °C for three hours. Samples of acetic acid-treated and control cells were then spread on the Petri dishes containing complete YPD (1% yeast extract, 2% bactopeptone, 2% glucose) media, incubated for 2–3 days and colonies counted.
The survival of H2O2 treatment was tested according to Madeo et al. [45]. Cells were grown in YPG until the culture reached the absorbance OD600 = 0.5–0.6; the cell suspension was then split into two flasks, and H2O2 to a final concentration of 0.6 mM was added to one; cells were incubated at 28 °C and after 3 h, samples were spread on the YPD plates. Colonies were counted after 2–3 days of cultivation at 28 °C.
Results of cell survival after acetic acid and H2O2 treatment were analyzed using one-way analysis of variance (ANOVA) followed by a Tukey post hoc test. Statistical significance is indicated in the corresponding figure.

5. Conclusions

Contradicting studies have described the role of gene BXI1/YBH3 in yeast Saccharomyces cerevisiae, suggesting that it may support survival in stress conditions or promote cell death by acting as a yeast BH3-only protein. Our data show that the absence of this gene in the deletion mutant does not affect the activity of ectopically expressed Bax, Bak, Bcl-XL, and Bcl-2 in a way BH3-only proteins would, nor is it required for their activity. On the other hand, we observed increased sensitivity of this mutant to treatment with acetic acid, a regulated cell death inducer. Together these results support the model, in which Bxi1p promotes cell survival by participation in stress signaling.

Author Contributions

Conceptualization, P.P. and M.M.; methodology, P.P.; formal analysis, M.M. and P.P.; investigation, M.I., V.K., G.K., Z.M. and P.C.; writing—original draft preparation, P.P.; writing—review and editing, P.P., M.M. and P.C.; visualization, M.M. and P.P.; supervision, P.P. and M.M.; project administration, P.P.; funding acquisition, P.P. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Scientific Grant Agency of the Ministry of Education of Slovak Republic VEGA, grant number 1/0459/20 and the Operation Program of Integrated Infrastructure for the project, Advancing University Capacity and Competence in Research, Development and Innovation, ITMS2014+: 313021X329, co-financed by the European Regional Development Fund.

Acknowledgments

Authors would like to thank Katarína Polčicová for the help with the manuscript.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Youle, R.J.; Strasser, A. The BCL-2 protein family: Opposing activities that mediate cell death. Nat. Rev. Mol. Cell Biol. 2008, 9, 47–59. [Google Scholar] [CrossRef] [PubMed]
  2. Aouacheria, A.; Rech de Laval, V.; Combet, C.; Hardwick, J.M. Evolution of Bcl-2 homology motifs: Homology versus homoplasy. Trends Cell Biol. 2013, 23, 103–111. [Google Scholar] [CrossRef] [PubMed]
  3. Moldoveanu, T.; Follis, A.V.; Kriwacki, R.W.; Green, D.R. Many players in BCL-2 family affairs. Trends Biochem. Sci. 2014, 39, 101–111. [Google Scholar] [CrossRef] [Green Version]
  4. Czabotar, P.E.; Garcia-Saez, A.J. Mechanisms of BCL-2 family proteins in mitochondrial apoptosis. Nat. Rev. Mol. Cell Biol. 2023, 1–17. [Google Scholar] [CrossRef] [PubMed]
  5. Carmona-Gutierrez, D.; Eisenberg, T.; Büttner, S.; Meisinger, C.; Kroemer, G.; Madeo, F. Apoptosis in yeast: Triggers, pathways, subroutines. Cell Death Differ. 2010, 17, 763–773. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Carmona-Gutierrez, D.; Bauer, M.A.; Zimmermann, A.; Aguilera, A.; Austriaco, N.; Ayscough, K.; Balzan, R.; Bar-Nun, S.; Barrientos, A.; Belenky, P.; et al. Guidelines and recommendations on yeast cell death nomenclature. Microb. Cell 2018, 5, 4–31. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  7. Sato, T.; Hanada, M.; Bodrug, S.; Irie, S.; Iwama, N.; Boise, L.H.; Thompson, C.B.; Golemis, E.; Fong, L.; Wang, H.G.; et al. Interactions among members of the Bcl-2 protein family analyzed with a yeast two-hybrid system. Proc. Natl. Acad. Sci. USA 1994, 91, 9238–9242. [Google Scholar] [CrossRef]
  8. Zha, H.; Fisk, H.A.; Yaffe, M.P.; Mahajan, N.; Herman, B.; Reed, J.C. Structure-function comparisons of the proapoptotic protein Bax in yeast and mammalian cells. Mol. Cell Biol. 1996, 16, 6494–6508. [Google Scholar] [CrossRef] [Green Version]
  9. Polčic, P.; Forte, M. Response of yeast to the regulated expression of proteins in the Bcl-2 family. Biochem. J. 2003, 374, 393–402. [Google Scholar] [CrossRef] [Green Version]
  10. Juhásová, B.; Mentel, M.; Bhatia-Kiššová, I.; Zeman, I.; Kolarov, J.; Forte, M.; Polčic, P. BH3-only protein Bim inhibits activity of antiapoptotic members of Bcl-2 family when expressed in yeast. FEBS Lett. 2011, 585, 2709–2713. [Google Scholar] [CrossRef] [Green Version]
  11. Gérecová, G.; Kopanicová, J.; Jaká, P.; Běhalová, L.; Juhásová, B.; Bhatia-Kiššová, I.; Forte, M.; Polčic, P.; Mentel, M. BH3-only proteins Noxa, Bik, Bmf, and Bid activate Bax and Bak indirectly when studied in yeast model. FEMS Yeast Res. 2013, 13, 747–754. [Google Scholar] [CrossRef] [Green Version]
  12. Polčic, P.; Mentel, M. Reconstituting the Mammalian Apoptotic Switch in Yeast. Genes 2020, 11, 145. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Manon, S. Yeast as a tool to decipher the molecular mechanisms underlying the functions of Bcl-2 family. Explor. Target. Antitumor Ther. 2022, 3, 128–148. [Google Scholar] [CrossRef]
  14. Xu, Q.; Reed, J.C. Bax inhibitor-1, a mammalian apoptosis suppressor identified by functional screening in yeast. Mol. Cell 1998, 1, 337–346. [Google Scholar] [CrossRef] [PubMed]
  15. Lisbona, F.; Rojas-Rivera, D.; Thielen, P.; Zamorano, S.; Todd, D.; Martinon, F.; Glavic, A.; Kress, C.; Lin, J.H.; Walter, P.; et al. BAX inhibitor-1 is a negative regulator of the ER stress sensor IRE1alpha. Mol. Cell 2009, 33, 679–691. [Google Scholar] [CrossRef] [Green Version]
  16. Lebeaupin, C.; Blanc, M.; Vallee, D.; Keller, H.; Bailly-Maitre, B. BAX inhibitor-1: Between stress and survival. FEBS J. 2020, 287, 1722–1736. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  17. Carrara, G.; Saraiva, N.; Gubser, C.; Johnson, B.F.; Smith, G.L. Six-transmembrane topology for Golgi anti-apoptotic protein (GAAP) and Bax inhibitor 1 (BI-1) provides model for the transmembrane Bax inhibitor-containing motif (TMBIM) family. J. Biol. Chem. 2012, 287, 15896–15905. [Google Scholar] [CrossRef] [Green Version]
  18. Lisak, D.A.; Schacht, T.; Enders, V.; Habicht, J.; Kiviluoto, S.; Schneider, J.; Henke, N.; Bultynck, G.; Methner, A. The transmembrane Bax inhibitor motif (TMBIM) containing protein family: Tissue expression, intracellular localization and effects on the ER CA(2)(+)-filling state. Biochim. Biophys. Acta 2015, 1853, 2104–2114. [Google Scholar] [CrossRef] [Green Version]
  19. Rojas-Rivera, D.; Hetz, C. TMBIM protein family: Ancestral regulators of cell death. Oncogene 2015, 34, 269–280. [Google Scholar] [CrossRef]
  20. Chae, H.J.; Ke, N.; Kim, H.R.; Chen, S.; Godzik, A.; Dickman, M.; Reed, J.C. Evolutionarily conserved cytoprotection provided by Bax Inhibitor-1 homologs from animals, plants, and yeast. Gene 2003, 323, 101–113. [Google Scholar] [CrossRef]
  21. Cebulski, J.; Malouin, J.; Pinches, N.; Cascio, V.; Austriaco, N. Yeast Bax inhibitor, Bxi1p, is an ER-localized protein that links the unfolded protein response and programmed cell death in Saccharomyces cerevisiae. PLoS ONE 2011, 6, e20882. [Google Scholar] [CrossRef]
  22. Büttner, S.; Ruli, D.; Vögtle, F.N.; Galluzzi, L.; Moitzi, B.; Eisenberg, T.; Kepp, O.; Habernig, L.; Carmona-Gutierrez, D.; Rockenfeller, P.; et al. A yeast BH3-only protein mediates the mitochondrial pathway of apoptosis. EMBO J. 2011, 30, 2779–2792. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Sedlak, T.W.; Oltvai, Z.N.; Yang, E.; Wang, K.; Boise, L.H.; Thompson, C.B.; Korsmeyer, S.J. Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. Proc. Natl. Acad. Sci. USA 1995, 92, 7834–7838. [Google Scholar] [CrossRef]
  24. Ottilie, S.; Diaz, J.L.; Chang, J.; Wilson, G.; Tuffo, K.M.; Weeks, S.; McConnell, M.; Wang, Y.; Oltersdorf, T.; Fritz, L.C. Structural and functional complementation of an inactive Bcl-2 mutant by Bax truncation. J. Biol. Chem. 1997, 272, 16955–16961. [Google Scholar] [CrossRef] [Green Version]
  25. Sattler, M.; Liang, H.; Nettesheim, D.; Meadows, R.P.; Harlan, J.E.; Eberstadt, M.; Yoon, H.S.; Shuker, S.B.; Chang, B.S.; Minn, A.J.; et al. Structure of Bcl-xL-Bak peptide complex: Recognition between regulators of apoptosis. Science 1997, 275, 983–986. [Google Scholar] [CrossRef] [PubMed]
  26. Petros, A.M.; Nettesheim, D.G.; Wang, Y.; Olejniczak, E.T.; Meadows, R.P.; Mack, J.; Swift, K.; Matayoshi, E.D.; Zhang, H.; Thompson, C.B.; et al. Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies. Protein Sci. 2000, 9, 2528–2534. [Google Scholar] [CrossRef]
  27. Liu, X.; Dai, S.; Zhu, Y.; Marrack, P.; Kappler, J.W. The structure of a Bcl-xL/Bim fragment complex: Implications for Bim function. Immunity 2003, 19, 341–352. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  28. Suzuki, M.; Youle, R.J.; Tjandra, N. Structure of Bax: Coregulation of dimer formation and intracellular localization. Cell 2000, 103, 645–654. [Google Scholar] [CrossRef] [Green Version]
  29. Pavlov, E.V.; Priault, M.; Pietkiewicz, D.; Cheng, E.H.; Antonsson, B.; Manon, S.; Korsmeyer, S.J.; Mannella, C.A.; Kinnally, K.W. A novel, high conductance channel of mitochondria linked to apoptosis in mammalian cells and Bax expression in yeast. J. Cell Biol. 2001, 155, 725–731. [Google Scholar] [CrossRef]
  30. Gross, A.; Pilcher, K.; Blachly-Dyson, E.; Basso, E.; Jockel, J.; Bassik, M.C.; Korsmeyer, S.J.; Forte, M. Biochemical and genetic analysis of the mitochondrial response of yeast to BAX and BCL-X(L). Mol. Cell Biol. 2000, 20, 3125–3136. [Google Scholar] [CrossRef] [Green Version]
  31. Priault, M.; Camougrand, N.; Chaudhuri, B.; Schaeffer, J.; Manon, S. Comparison of the effects of bax-expression in yeast under fermentative and respiratory conditions: Investigation of the role of adenine nucleotides carrier and cytochrome c. FEBS Lett. 1999, 456, 232–238. [Google Scholar] [CrossRef] [Green Version]
  32. Kiššová, I.; Polčic, P.; Kempná, P.; Zeman, I.; Šabová, Ľ.; Kolarov, J. The cytotoxic action of Bax on yeast cells does not require mitochondrial ADP/ATP carrier but may be related to its import to the mitochondria. FEBS Lett. 2000, 471, 113–118. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Zara, V.; Dietmeier, K.; Palmisano, A.; Vozza, A.; Rassow, J.; Palmieri, F.; Pfanner, N. Yeast mitochondria lacking the phosphate carrier/p32 are blocked in phosphate transport but can import preproteins after regeneration of a membrane potential. Mol. Cell Biol. 1996, 16, 6524–6531. [Google Scholar] [CrossRef] [Green Version]
  34. Bharathi, V.; Girdhar, A.; Patel, B.K. Role of CNC1 gene in TDP-43 aggregation-induced oxidative stress-mediated cell death in S. cerevisiae model of ALS. Biochim. Biophys. Acta Mol. Cell Res. 2021, 1868, 118993. [Google Scholar] [CrossRef] [PubMed]
  35. Manzanares-Estreder, S.; Pascual-Ahuir, A.; Proft, M. Stress-Activated Degradation of Sphingolipids Regulates Mitochondrial Function and Cell Death in Yeast. Oxid. Med. Cell. Longev. 2017, 2017, 2708345. [Google Scholar] [CrossRef] [Green Version]
  36. Jones, N.K.; Arab, N.T.; Eid, R.; Gharib, N.; Sheibani, S.; Vali, H.; Khoury, C.; Murray, A.; Boucher, E.; Mandato, C.A.; et al. Human Thyroid Cancer-1 (TC-1) is a vertebrate specific oncogenic protein that protects against copper and pro-apoptotic genes in yeast. Microb. Cell 2015, 2, 247–255. [Google Scholar] [CrossRef] [Green Version]
  37. Chang, Y.; Bruni, R.; Kloss, B.; Assur, Z.; Kloppmann, E.; Rost, B.; Hendrickson, W.A.; Liu, Q. Structural basis for a pH-sensitive calcium leak across membranes. Science 2014, 344, 1131–1135. [Google Scholar] [CrossRef] [Green Version]
  38. Mullin, J.; Kalhorn, J.; Mello, N.; Raffa, A.; Strakosha, A.; Austriaco, O.P.N. Yeast Bax Inhibitor (Bxi1p/Ybh3p) is a Calcium Channel in E. coli. bioRxiv 2019, 722926. [Google Scholar] [CrossRef]
  39. Philippaert, K.; Roden, M.; Lisak, D.; Bueno, D.; Jelenik, T.; Radyushkin, K.; Schacht, T.; Mesuere, M.; Wullner, V.; Herrmann, A.K.; et al. Bax inhibitor-1 deficiency leads to obesity by increasing Ca(2+)-dependent insulin secretion. J. Mol. Med. 2020, 98, 849–862. [Google Scholar] [CrossRef]
  40. Bellí, G.; Garí, E.; Piedrafita, L.; Aldea, M.; Herrero, E. An activator/repressor dual system allows tight tetracycline-regulated gene expression in budding yeast. Nucleic Acids Res. 1998, 26, 942–947. [Google Scholar] [CrossRef] [Green Version]
  41. Schiestl, R.H.; Gietz, R.D. High efficiency transformation of intact yeast cells using single stranded nucleic acids as a carrier. Curr. Genet. 1989, 16, 339–346. [Google Scholar] [CrossRef]
  42. Mumberg, D.; Muller, R.; Funk, M. Regulatable promoters of Saccharomyces cerevisiae: Comparison of transcriptional activity and their use for heterologous expression. Nucleic Acids Res. 1994, 22, 5767–5768. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Juhásová, B.; Bhatia-Kiššová, I.; Polčicová, K.; Mentel, M.; Forte, M.; Polčic, P. Reconstitution of interactions of Murine gammaherpesvirus 68 M11 with Bcl-2 family proteins in yeast. Biochem. Biophys. Res. Commun. 2011, 407, 783–787. [Google Scholar] [CrossRef]
  44. Ludovico, P.; Sousa, M.J.; Silva, M.T.; Leao, C.L.; Corte-Real, M. Saccharomyces cerevisiae commits to a programmed cell death process in response to acetic acid. Microbiology 2001, 147, 2409–2415. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Madeo, F.; Fröhlich, E.; Ligr, M.; Grey, M.; Sigrist, S.J.; Wolf, D.H.; Fröhlich, K.U. Oxygen stress: A regulator of apoptosis in yeast. J. Cell Biol. 1999, 145, 757–767. [Google Scholar] [CrossRef] [PubMed]
Ijms 24 12011 g001 550
Figure 1. BXI1 has no effect on the growth of wild-type and Bax-expressing yeast cells. CML282 (wt) and CML∆bxi1 (∆bxi1) cells not containing (control) or containing galactose inducible Bax gene (Bax) were cultivated in glucose media and cell suspensions were spotted onto SC plates containing indicated carbon source. The growth was assessed after 3 days.
Figure 1. BXI1 has no effect on the growth of wild-type and Bax-expressing yeast cells. CML282 (wt) and CML∆bxi1 (∆bxi1) cells not containing (control) or containing galactose inducible Bax gene (Bax) were cultivated in glucose media and cell suspensions were spotted onto SC plates containing indicated carbon source. The growth was assessed after 3 days.
Ijms 24 12011 g001
Ijms 24 12011 g002 550
Figure 2. BXI1 has no effect on the pro-survival activity of Bcl-2 and Bcl-XL. CML282 (wt) and CML∆bxi1 (∆bxi1) cells not containing (control) or containing galactose inducible Bax gene (Bax) were transformed with a plasmid containing doxycycline-inducible HA-Bcl-XL (Bcl-XL), Bcl-2 (Bcl-2), or with empty vector (not indicated). Cells were cultivated in glucose-containing SC media and cell suspensions were spotted onto SC plates containing indicated carbon source and concentration of doxycycline. The growth was assessed after 3 days.
Figure 2. BXI1 has no effect on the pro-survival activity of Bcl-2 and Bcl-XL. CML282 (wt) and CML∆bxi1 (∆bxi1) cells not containing (control) or containing galactose inducible Bax gene (Bax) were transformed with a plasmid containing doxycycline-inducible HA-Bcl-XL (Bcl-XL), Bcl-2 (Bcl-2), or with empty vector (not indicated). Cells were cultivated in glucose-containing SC media and cell suspensions were spotted onto SC plates containing indicated carbon source and concentration of doxycycline. The growth was assessed after 3 days.
Ijms 24 12011 g002
Ijms 24 12011 g003 550
Figure 3. The absence of Mir1 does not affect the activity of proteins of the Bcl-2 family in yeast. (a) CML282 (wt), CML∆bxi1 (∆bxi1) and CML∆mir1 (∆mir1) cells not containing (control) or containing galactose inducible Bax gene (Bax) were cultivated in glucose media and cell suspensions were spotted onto SC plates containing indicated carbon source. (b) CML282 and CML∆mir1 cells not containing or containing galactose inducible Bax gene were transformed with plasmid containing doxycycline-inducible HABcl-XL (Bcl-XL), or with empty vector (not indicated). Cells were cultivated in glucose-containing SC media and cell suspensions were spotted onto SC plates containing indicated carbon source and concentration of doxycycline. The growth was assessed after 4 days.
Figure 3. The absence of Mir1 does not affect the activity of proteins of the Bcl-2 family in yeast. (a) CML282 (wt), CML∆bxi1 (∆bxi1) and CML∆mir1 (∆mir1) cells not containing (control) or containing galactose inducible Bax gene (Bax) were cultivated in glucose media and cell suspensions were spotted onto SC plates containing indicated carbon source. (b) CML282 and CML∆mir1 cells not containing or containing galactose inducible Bax gene were transformed with plasmid containing doxycycline-inducible HABcl-XL (Bcl-XL), or with empty vector (not indicated). Cells were cultivated in glucose-containing SC media and cell suspensions were spotted onto SC plates containing indicated carbon source and concentration of doxycycline. The growth was assessed after 4 days.
Ijms 24 12011 g003
Ijms 24 12011 g004 550
Figure 4. The absence of Mir1 does not affect the effect of Bxi1 on the activity of proteins of the Bcl-2 family in yeast. (a) CML282 (wt) CML∆bxi1 (∆bxi1) and CML∆bxi1∆mir1 (∆bxi1∆mir1) cells not containing (control) or containing galactose inducible Bax gene (Bax) were cultivated in glucose media and cell suspensions were spotted onto SC plates containing indicated carbon source. (b) CML282∆mir1 (∆mir1) and CML∆bxi1∆mir1 (∆bxi1∆mir1) cells not containing (control) or containing galactose inducible Bax gene were transformed with a plasmid containing doxycycline-inducible HABcl-XL (Bcl-XL), or with empty vector (not indicated). Cells were cultivated in glucose-containing SC media and cell suspensions were spotted onto SC plates containing indicated carbon source and concentration of doxycycline. The growth was assessed after 4 days.
Figure 4. The absence of Mir1 does not affect the effect of Bxi1 on the activity of proteins of the Bcl-2 family in yeast. (a) CML282 (wt) CML∆bxi1 (∆bxi1) and CML∆bxi1∆mir1 (∆bxi1∆mir1) cells not containing (control) or containing galactose inducible Bax gene (Bax) were cultivated in glucose media and cell suspensions were spotted onto SC plates containing indicated carbon source. (b) CML282∆mir1 (∆mir1) and CML∆bxi1∆mir1 (∆bxi1∆mir1) cells not containing (control) or containing galactose inducible Bax gene were transformed with a plasmid containing doxycycline-inducible HABcl-XL (Bcl-XL), or with empty vector (not indicated). Cells were cultivated in glucose-containing SC media and cell suspensions were spotted onto SC plates containing indicated carbon source and concentration of doxycycline. The growth was assessed after 4 days.
Ijms 24 12011 g004
Ijms 24 12011 g005 550
Figure 5. The survival of ∆bxi1 cells after treatment with acetic acid and hydrogen peroxide. Cells of the CML282 (wt) and CML∆bxi1 strain (∆bxi1) were treated with (a) 0.6 mM hydrogen peroxide or with (b) 80 mM acetic acid for 180 min, as described in the section Material and Methods. Survival corresponds to the ratio of the number of colonies formed by treated cells to the number of colonies formed by control (untreated) cells. The average of three independent experiments with standard errors is shown. Asterisk (*) indicates a statistical significance p < 0.05 of differences between mutants and the wild type.
Figure 5. The survival of ∆bxi1 cells after treatment with acetic acid and hydrogen peroxide. Cells of the CML282 (wt) and CML∆bxi1 strain (∆bxi1) were treated with (a) 0.6 mM hydrogen peroxide or with (b) 80 mM acetic acid for 180 min, as described in the section Material and Methods. Survival corresponds to the ratio of the number of colonies formed by treated cells to the number of colonies formed by control (untreated) cells. The average of three independent experiments with standard errors is shown. Asterisk (*) indicates a statistical significance p < 0.05 of differences between mutants and the wild type.
Ijms 24 12011 g005
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Mentel, M.; Illová, M.; Krajčovičová, V.; Kroupová, G.; Mannová, Z.; Chovančíková, P.; Polčic, P. Yeast Bax Inhibitor (Bxi1p/Ybh3p) Is Not Required for the Action of Bcl-2 Family Proteins on Cell Viability. Int. J. Mol. Sci. 2023, 24, 12011. https://doi.org/10.3390/ijms241512011

AMA Style

Mentel M, Illová M, Krajčovičová V, Kroupová G, Mannová Z, Chovančíková P, Polčic P. Yeast Bax Inhibitor (Bxi1p/Ybh3p) Is Not Required for the Action of Bcl-2 Family Proteins on Cell Viability. International Journal of Molecular Sciences. 2023; 24(15):12011. https://doi.org/10.3390/ijms241512011

Chicago/Turabian Style

Mentel, Marek, Miroslava Illová, Veronika Krajčovičová, Gabriela Kroupová, Zuzana Mannová, Petra Chovančíková, and Peter Polčic. 2023. "Yeast Bax Inhibitor (Bxi1p/Ybh3p) Is Not Required for the Action of Bcl-2 Family Proteins on Cell Viability" International Journal of Molecular Sciences 24, no. 15: 12011. https://doi.org/10.3390/ijms241512011

APA Style

Mentel, M., Illová, M., Krajčovičová, V., Kroupová, G., Mannová, Z., Chovančíková, P., & Polčic, P. (2023). Yeast Bax Inhibitor (Bxi1p/Ybh3p) Is Not Required for the Action of Bcl-2 Family Proteins on Cell Viability. International Journal of Molecular Sciences, 24(15), 12011. https://doi.org/10.3390/ijms241512011

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop